Immunomodulatory intervention in sepsis by multidrug-resistant Pseudomonas aeruginosa with thalidomide: an experimental study

BACKGROUND: Thalidomide is an inhibitor of tumour necrosis factor-alpha (TNFα) that has been proven effective for the treatment of experimental sepsis by Escherichia coli. It was tested whether it might behave as an effective immunomodulator in experimental sepsis by multidrug-resistant (MDR) Pseudo...

Descripción completa

Detalles Bibliográficos
Autores principales: Giamarellos-Bourboulis, Evangelos J, Bolanos, Nikolaos, Laoutaris, George, Papadakis, Vassilios, Koussoulas, Vassilios, Perrea, Despina, Karayannacos, Panayotis E, Giamarellou, Helen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1185538/
https://www.ncbi.nlm.nih.gov/pubmed/15978135
http://dx.doi.org/10.1186/1471-2334-5-51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1185538/
https://www.ncbi.nlm.nih.gov/pubmed/15978135
http://dx.doi.org/10.1186/1471-2334-5-51

Ejemplares similares